IL6 and cancer: According to recent study findings, IL-6 and other proinflammatory cytokines of this family, including oncostatin M, directly stimulate the invasion of cancer cells through basement membrane degradation due to metalloproteinase (MMP) overexpression, induce epithelial-mesenchymal transition of ovarian epithelial cells, and increase resistance to chemotherapy [13].